Name Patient Programs / Section 21
Where approved treatments are unavailable, ineffective or inappropriate, access to unregistered medicines can be vital for specific patients.
In these cases, these unregistered medicines may offer an alternative treatment option that could potentially improve patient outcomes.
These medicines are available on a Named Patient Programs.
Key Oncologics (Pty) Ltd offers comprehensive support to physicians by managing all aspects of accessing these unregistered treatments.
Services include:
-
Handling regulatory administration
-
Importation
-
Warehousing and distribution